AsiDNA Treatment Induces Cumulative Antitumor Efficacy with a Low Probability of Acquired Resistance

Wael Jdey, Maria Kozlak, Sergey Alekseev, Sylvain Thierry, Pauline Lascaux, Pierre-Marie Girard, Françoise Bono, Marie Dutreix

Open source

DOI
10.1016/j.neo.2019.06.006
Published
2019-09
Container
Neoplasia
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.neo.2019.06.006,
  title = {AsiDNA Treatment Induces Cumulative Antitumor Efficacy with a Low Probability of Acquired Resistance},
  author = {Wael Jdey and Maria Kozlak and Sergey Alekseev and Sylvain Thierry and Pauline Lascaux and Pierre-Marie Girard and Françoise Bono and Marie Dutreix},
  year = {2019},
  journal = {Neoplasia},
  doi = {10.1016/j.neo.2019.06.006},
  url = {https://doi.org/10.1016/j.neo.2019.06.006}
}

RIS

TY  - JOUR
TI  - AsiDNA Treatment Induces Cumulative Antitumor Efficacy with a Low Probability of Acquired Resistance
AU  - Wael Jdey
AU  - Maria Kozlak
AU  - Sergey Alekseev
AU  - Sylvain Thierry
AU  - Pauline Lascaux
AU  - Pierre-Marie Girard
AU  - Françoise Bono
AU  - Marie Dutreix
PY  - 2019
JO  - Neoplasia
DO  - 10.1016/j.neo.2019.06.006
UR  - https://doi.org/10.1016/j.neo.2019.06.006
ER  - 

APA

Jdey, W., Kozlak, M., Alekseev, S., Thierry, S., Lascaux, P., Girard, P., Bono, F., & Dutreix, M. (2019). AsiDNA Treatment Induces Cumulative Antitumor Efficacy with a Low Probability of Acquired Resistance. Neoplasia. https://doi.org/10.1016/j.neo.2019.06.006

Source records